Management of Gastropathy and Gastric Vascular Ectasia in Portal Hypertension

Clinics in Liver Disease

Volumn 14, Issue 2, 2010, Pages 281-295

  Ripoll, Cristina ^a   Garcia Tsao, Guadalupe ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Gastric antral vascular ectasia; Management; Portal hypertension; Portal hypertensive gastropathy

Indexed keywords

NEODYMIUM; PLACEBO; PROPRANOLOL; SOMATOSTATIN; TERLIPRESSIN;

ABLATION THERAPY; ACUTE DISEASE; ANAMNESIS; ANEMIA; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG MEGADOSE; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL HYPERTENSIVE GASTROPATHY; PREVALENCE; RECURRENT DISEASE; REVIEW; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH DISEASE; STOMACH HEMORRHAGE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ABLATION TECHNIQUES; ADRENERGIC BETA-ANTAGONISTS; ANEMIA, IRON-DEFICIENCY; BIOPSY; BLOOD TRANSFUSION; ENDOSCOPES, GASTROINTESTINAL; GASTRIC ANTRAL VASCULAR ECTASIA; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; STOMACH DISEASES; TREATMENT OUTCOME;

EID: 77953227030     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2010.03.013     Document Type: Review

References (99)

1. Primignani M., Carpinelli L., Preatoni P., et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119 1 (2000) 181-187
2. Bresci G., Parisi G., and Capria A. Clinical relevance of colonic lesions in cirrhotic patients with portal hypertension. Endoscopy 38 8 (2006) 830-835
3. Figueiredo P., Almeida N., Lerias C., et al. Effect of portal hypertension in the small bowel: an endoscopic approach. Dig Dis Sci 53 8 (2008) 2144-2150
4. Goulas S., Triantafyllidou K., Karagiannis S., et al. Capsule endoscopy in the investigation of patients with portal hypertension and anemia. Can J Gastroenterol 22 5 (2008) 469-474
5. Higaki N., Matsui H., Imaoka H., et al. Characteristic endoscopic features of portal hypertensive enteropathy. J Gastroenterol 43 5 (2008) 327-331
6. Ito K., Shiraki K., Sakai T., et al. Portal hypertensive colopathy in patients with liver cirrhosis. World J Gastroenterol 11 20 (2005) 3127-3130
7. Menchen L., Ripoll C., Marin-Jimenez I., et al. Prevalence of portal hypertensive duodenopathy in cirrhosis: clinical and haemodynamic features. Eur J Gastroenterol Hepatol 18 6 (2006) 649-653
8. Misra S.P., Dwivedi M., and Misra V. Prevalence and factors influencing hemorrhoids, anorectal varices, and colopathy in patients with portal hypertension. Endoscopy 28 4 (1996) 340-345
9. Sarin S.K., Shahi H.M., Jain M., et al. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol 95 10 (2000) 2888-2893
10. Fontana R.J., Sanyal A.J., Mehta S., et al. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol 101 5 (2006) 983-992
11. Merli M., Nicolini G., Angeloni S., et al. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol 99 10 (2004) 1959-1965
12. D'Amico G., Montalbano L., Traina M., et al. Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology 99 6 (1990) 1558-1564
13. Yuksel O., Koklu S., Arhan M., et al. Effects of esophageal varice eradication on portal hypertensive gastropathy and fundal varices: a retrospective and comparative study. Dig Dis Sci 51 1 (2006) 27-30
14. Hou M.C., Lin H.C., Chen C.H., et al. Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation. Gastrointest Endosc 42 2 (1995) 139-144
15. Yoshikawa I., Murata I., Nakano S., et al. Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow. Am J Gastroenterol 93 1 (1998) 71-74
16. Groszmann R.J., and Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39 2 (2004) 280-282
17. Bellis L., Nicodemo S., Galossi A., et al. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis. J Gastrointestin Liver Dis 16 3 (2007) 273-277
18. Quintero E., Pique J.M., Bombi J.A., et al. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology 93 5 (1987) 1054-1061
19. Iwao T., Toyonaga A., Sumino M., et al. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 102 6 (1992) 2060-2065
20. Sarin S.K., Misra S.P., Singal A., et al. Evaluation of the incidence and significance of the "mosaic pattern" in patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Am J Gastroenterol 83 11 (1988) 1235-1239
21. Papazian A., Braillon A., Dupas J.L., et al. Portal hypertensive gastric mucosa: an endoscopic study. Gut 27 10 (1986) 1199-1203
22. McCormack T.T., Sims J., Eyre-Brook I., et al. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?. Gut 26 11 (1985) 1226-1232
23. Kawanaka H., Tomikawa M., Jones M.K., et al. Defective mitogen-activated protein kinase (ERK2) signaling in gastric mucosa of portal hypertensive rats: potential therapeutic implications. Hepatology 34 5 (2001) 990-999
24. Kinjo N., Kawanaka H., Akahoshi T., et al. Significance of ERK nitration in portal hypertensive gastropathy and its therapeutic implications. Am J Physiol Gastrointest Liver Physiol 295 5 (2008) G1016-G1024
25. Sarfeh I.J., Soliman H., Waxman K., et al. Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury. Dig Dis Sci 34 2 (1989) 225-228
26. Sarfeh I.J., and Tarnawski A. Gastric mucosal vasculopathy in portal hypertension. Gastroenterology 93 5 (1987) 1129-1131
27. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 1 (2005) 167-176
28. Stewart C.A., and Sanyal A.J. Grading portal gastropathy: validation of a gastropathy scoring system. Am J Gastroenterol 98 8 (2003) 1758-1765
29. Canlas K.R., Dobozi B.M., Lin S., et al. Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia. J Clin Gastroenterol 42 7 (2008) 844-848
30. Barakat M., Mostafa M., Mahran Z., et al. Portal hypertensive duodenopathy: clinical, endoscopic, and histopathologic profiles. Am J Gastroenterol 102 12 (2007) 2793-2802
31. Erden A., Idilman R., Erden I., et al. Veins around the esophagus and the stomach: do their calibrations provide a diagnostic clue for portal hypertensive gastropathy?. Clin Imaging 33 1 (2009) 22-24
32. Ishihara K., Ishida R., Saito T., et al. Computed tomography features of portal hypertensive gastropathy. J Comput Assist Tomogr 28 6 (2004) 832-835
33. de Franchis R., Eisen G.M., Laine L., et al. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology 47 5 (2008) 1595-1603
34. Perez-Ayuso R.M., Pique J.M., Bosch J., et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 337 8755 (1991) 1431-1434
35. Gostout C.J., Viggiano T.R., and Balm R.K. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol 88 12 (1993) 2030-2033
36. Hosking S.W. Congestive gastropathy in portal hypertension: variations in prevalence. Hepatology 10 2 (1989) 257-258
37. Wagatsuma Y., Naritaka Y., Shimakawa T., et al. Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy. Hepatogastroenterology 53 68 (2006) 171-174
38. Karajeh M.A., Hurlstone D.P., Stephenson T.J., et al. Refractory bleeding from portal hypertensive gastropathy: a further novel role for thalidomide therapy?. Eur J Gastroenterol Hepatol 18 5 (2006) 545-548
39. Cremers M.I., Oliveira A.P., Alves A.L., et al. Portal hypertensive gastropathy: treatment with corticosteroids. Endoscopy 34 2 (2002) 177
40. Kamath P.S., Lacerda M., Ahlquist D.A., et al. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 118 5 (2000) 905-911
41. Mezawa S., Homma H., Ohta H., et al. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol 96 4 (2001) 1155-1159
42. Urata J., Yamashita Y., Tsuchigame T., et al. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol 13 10 (1998) 1061-1067
43. Vignali C., Bargellini I., Grosso M., et al. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol 185 2 (2005) 472-480
44. Orloff M.J., Orloff M.S., Orloff S.L., et al. Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt. Hepatology 21 4 (1995) 1011-1017
45. Soin A.S., Acharya S.K., Mathur M., et al. Portal hypertensive gastropathy in noncirrhotic patients. The effect of lienorenal shunts. J Clin Gastroenterol 26 1 (1998) 64-67 [discussion: 68]
46. Herrera S., Bordas J.M., Llach J., et al. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc 68 3 (2008) 440-446
47. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46 3 (2007) 922-938
48. Fernandez J., Ruiz del Arbol L., Gomez C., et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131 4 (2006) 1049-1056 [quiz: 1285]
49. Villanueva C., Planella M., Aracil C., et al. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose. Am J Gastroenterol 100 3 (2005) 624-630
50. Cirera I., Feu F., Luca A., et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology 22 1 (1995) 106-111
51. Bruha R., Marecek Z., Spicak J., et al. Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding. Hepatogastroenterology 49 46 (2002) 1161-1166
52. Zhou Y., Qiao L., Wu J., et al. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. J Gastroenterol Hepatol 17 9 (2002) 973-979
53. Kouroumalis E.A., Koutroubakis I.E., and Manousos O.N. Somatostatin for acute severe bleeding from portal hypertensive gastropathy. Eur J Gastroenterol Hepatol 10 6 (1998) 509-512
54. Gostout C.J., Viggiano T.R., Ahlquist D.A., et al. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol 15 3 (1992) 256-263
55. Tobin R.W., Hackman R.C., Kimmey M.B., et al. Bleeding from gastric antral vascular ectasia in marrow transplant patients. Gastrointest Endosc 44 3 (1996) 223-229
56. Liberski S.M., McGarrity T.J., Hartle R.J., et al. The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy. Gastrointest Endosc 40 5 (1994) 584-587
57. Yamamoto M., Takahashi H., Akaike J., et al. Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol 37 4 (2008) 315-316
58. Dulai G.S., Jensen D.M., Kovacs T.O., et al. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy 36 1 (2004) 68-72
59. Payen J.L., Cales P., Voigt J.J., et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology 108 1 (1995) 138-144
60. Lecleire S., Ben-Soussan E., Antonietti M., et al. Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc 67 2 (2008) 219-225
61. Ward E.M., Raimondo M., Rosser B.G., et al. Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol 38 10 (2004) 898-900
62. Spahr L., Villeneuve J.P., Dufresne M.P., et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 44 5 (1999) 739-742
63. Vincent C., Pomier-Layrargues G., Dagenais M., et al. Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis. Liver Transpl 8 8 (2002) 717-720
64. Saperas E., Perez Ayuso R.M., Poca E., et al. Increased gastric PGE2 biosynthesis in cirrhotic patients with gastric vascular ectasia. Am J Gastroenterol 85 2 (1990) 138-144
65. Charneau J., Petit R., Cales P., et al. Antral motility in patients with cirrhosis with or without gastric antral vascular ectasia. Gut 37 4 (1995) 488-492
66. Burak K.W., Lee S.S., and Beck P.L. Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome. Gut 49 6 (2001) 866-872
67. Suit P.F., Petras R.E., Bauer T.W., et al. Gastric antral vascular ectasia. A histologic and morphometric study of "the watermelon stomach". Am J Surg Pathol 11 10 (1987) 750-757
68. Sato T., Yamazaki K., Toyota J., et al. Efficacy of argon plasma coagulation for gastric antral vascular ectasia associated with chronic liver disease. Hepatol Res 32 2 (2005) 121-126
69. Yusoff I., Brennan F., Ormonde D., et al. Argon plasma coagulation for treatment of watermelon stomach. Endoscopy 34 5 (2002) 407-410
70. Sebastian S., McLoughlin R., Qasim A., et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results. Dig Liver Dis 36 3 (2004) 212-217
71. Roman S., Saurin J.C., Dumortier J., et al. Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy 35 12 (2003) 1024-1028
72. Kwan V., Bourke M.J., Williams S.J., et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol 101 1 (2006) 58-63
73. Probst A., Scheubel R., and Wienbeck M. Treatment of watermelon stomach (GAVE syndrome) by means of endoscopic argon plasma coagulation (APC): long-term outcome. Z Gastroenterol 39 6 (2001) 447-452
74. Fuccio L., Zagari R.M., Serrani M., et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia-related bleeding in patients with liver cirrhosis. Digestion 79 3 (2009) 143-150
75. Baudet J.S., Salata H., Soler M., et al. Hyperplastic gastric polyps after argon plasma coagulation treatment of gastric antral vascular ectasia (GAVE). Endoscopy 39 Suppl 1 (2007) E320
76. Izquierdo S., Rey E., Gutierrez Del Olmo A., et al. Polyp as a complication of argon plasma coagulation in watermelon stomach. Endoscopy 37 9 (2005) 921
77. Farooq F.T., Wong R.C., Yang P., et al. Gastric outlet obstruction as a complication of argon plasma coagulation for watermelon stomach. Gastrointest Endosc 65 7 (2007) 1090-1092
78. Labenz J., and Borsch G. Bleeding watermelon stomach treated by Nd-YAG laser photocoagulation. Endoscopy 25 3 (1993) 240-242
79. Mathou N.G., Lovat L.B., Thorpe S.M., et al. Nd:YAG laser induces long-term remission in transfusion-dependent patients with watermelon stomach. Lasers Med Sci 18 4 (2004) 213-218
80. Selinger R.R., McDonald G.B., Hockenbery D.M., et al. Efficacy of neodymium:YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant. Bone Marrow Transplant 37 2 (2006) 191-197
81. Ng I., Lai K.C., and Ng M. Clinical and histological features of gastric antral vascular ectasia: successful treatment with endoscopic laser therapy. J Gastroenterol Hepatol 11 3 (1996) 270-274
82. Petrini Jr. J.L., and Johnston J.H. Heat probe treatment for antral vascular ectasia. Gastrointest Endosc 35 4 (1989) 324-328
83. Kantsevoy S.V., Cruz-Correa M.R., Vaughn C.A., et al. Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesions of the GI tract: a pilot study. Gastrointest Endosc 57 3 (2003) 403-406
84. Cho S., Zanati S., Yong E., et al. Endoscopic cryotherapy for the management of gastric antral vascular ectasia. Gastrointest Endosc 68 5 (2008) 895-902
85. Wells C.D., Harrison M.E., Gurudu S.R., et al. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc 68 2 (2008) 231-236
86. Gill K.R., Raimondo M., and Wallace M.B. Endoscopic band ligation for the treatment of gastric antral vascular ectasia. Gastrointest Endosc 69 6 (2009) 1194
87. Tran A., Villeneuve J.P., Bilodeau M., et al. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol 94 10 (1999) 2909-2911
88. Manning R.J. Estrogen/progesterone treatment of diffuse antral vascular ectasia. Am J Gastroenterol 90 1 (1995) 154-156
89. Moss S.F., Ghosh P., Thomas D.M., et al. Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone. Gut 33 5 (1992) 715-717
90. Nardone G., Rocco A., Balzano T., et al. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 13 11 (1999) 1429-1436
91. Bhowmick B.K. Watermelon stomach treated with oral corticosteroid. J R Soc Med 86 1 (1993) 52
92. Suzuki T., Hirano M., and Oka H. Long-term corticosteroid therapy for gastric antral vascular ectasia. Am J Gastroenterol 91 9 (1996) 1873-1874
93. McCormick P.A., Ooi H., and Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut 42 5 (1998) 750-752
94. Dunne K.A., Hill J., and Dillon J.F. Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide. Eur J Gastroenterol Hepatol 18 4 (2006) 455-456
95. Cabral J.E., Pontes J.M., Toste M., et al. Watermelon stomach: treatment with a serotonin antagonist. Am J Gastroenterol 86 7 (1991) 927-928
96. Shibukawa G., Irisawa A., Sakamoto N., et al. Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis: relapse after endoscopic treatment by argon plasma coagulation. Intern Med 46 6 (2007) 279-283
97. Mann N.S., and Rachut E. Gastric antral vascular ectasia causing severe hypoalbuminemia and anemia cured by antrectomy. J Clin Gastroenterol 34 3 (2002) 284-286
98. Pljesa S., Golubovic G., Tomasevic R., et al. "Watermelon stomach" in patients on chronic hemodialysis. Ren Fail 27 5 (2005) 643-646
99. Jabbari M., Cherry R., Lough J.O., et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 87 5 (1984) 1165-1170